IZMO Ltd

- IZMO Limited is in advanced talks to raise funds for its subsidiary FrogData USA through equity, targeting between 10% to 15% stake dilution. - The valuation aimed for FrogData is between $60 million to $80 million. - This fundraising is a fresh capital raise (not a sale) to be used mainly for sales expansion and tech team growth in the U.S. - The process has started earlier this year but was delayed due to personal reasons; expected to close in the next quarter. - There is no mention of any new debt fundraising. - The company might also consider equity dilution in the parent company in the next quarter, which could attract domestic institutional investors once market cap crosses Rs. 1,000 crores.

- IZMO is raising funds at the subsidiary level, specifically in FrogData USA, aiming to divest 10-15% stake with a valuation target of $60-$80 million, to fuel expansion in the U.S. (Page 12-13). - Capex/fundraise proceeds for FrogData will be used to expand sales and office presence in the U.S., aiming to increase coverage from 5 states to around 25 states, including hiring technical resources for growth (Page 12). - Establishment of a new subsidiary, izmo Microsystems Private Limited, to develop technologies for electric vehicles (EVs), including battery management systems and related software/hardware, aiming to tap into the growing EV market (Page 6). - Ongoing R&D expenditure is maintained to create new products relevant for the next 3 to 10 years; in absolute terms R&D spend remains stable, but as a percentage of revenue, it is decreasing due to growing topline (Page 10-12). - Opening new offices in Spain and Germany to support European expansion (Page 15).

- IZMO Limited targets a 30% to 40% consolidated revenue growth for FY '25. - The medium-term aim is to achieve a 500 crore turnover within the next 3 to 4 years (by FY '27-'28), which is considered aggressive but possible. - Growth drivers include new client additions across geographies and expanded business from existing clients. - Germany and Spain are key focus regions for expansion, with expectations of multi-million euro revenues from these markets once fully operational. - FrogData, the AI analytics subsidiary, is expected to grow rapidly, potentially doubling (up to 100% growth), contributing significantly to revenue and margins. - Margin improvement is anticipated due to controlled costs despite growth. - New product launches (e.g., VR product by FY '25 end) and continuous R&D support sustained growth. - Europe and the U.S. remain primary markets, with potential future expansions in South America.

- IZMO Limited targets 30% to 40% consolidated top-line growth for FY 2025. - Internal projection aims to reach a ₹500 crore turnover by FY 2027-28, considered aggressive but achievable with sustained 30%-40% CAGR. - EBITDA margins are expected to improve or at least remain stable, as costs will largely remain flat despite growth. - Q4 FY24 EBITDA margin was about 24%, and FY24 average margin taken as a base is 21.5%. - PAT margins improved year-on-year, with continued margin expansion anticipated from cost control measures and growing profitable segments like FrogData. - EPS for FY 24 stood at ₹19.30, with expectations for growth aligned with revenue and margin expansion. - FrogData business, contributing significantly to margins (30%-40%), aims for 75%-100% revenue growth, which will positively impact overall profitability. - R&D expenditure will remain constant in absolute terms, thus becoming a smaller % of revenue, aiding margin improvement.

- IZMO Limited is experiencing a strong pipeline of orders, evidenced by several new client additions in key markets across the U.S. and Europe. - Large contracts are coming in from existing OEM clients as projects previously done gain traction and are rolled out at scale (e.g., Renault, Stellantis, Hertz). - Expansion in Europe, particularly Germany and Spain, is expected to contribute significantly to new order inflows. - The company’s internal target is aggressive growth with a revenue goal of 500 crore in the near term, supported by these ongoing and upcoming contracts. - Pricing increases and new product introductions continue to support order book growth. - Management expressed confidence in maintaining 30%-40% revenue growth, indicating a healthy and expanding order backlog. - Details of specific pending order values were not explicitly disclosed in the call.